What You Should Know:
– Amwell, a provider of digital healthcare solutions, has announced that its Chief Financial Officer (CFO), Mark Hirschhorn, will assume an expanded role as Chief Operating Officer (COO), effective January 1, 2025.
– The alignment reflects Amwell’s focus on streamlining operations and scaling its business to meet the increasing demand for digital healthcare services.
Expanded Responsibilities for CFO
In his new role, Hirschhorn will oversee Amwell’s operational and growth strategies, including leadership of the clinical, sales, and marketing teams. He will retain his responsibilities as CFO, providing a unified approach to financial and operational management.
“I am eager to take on the additional responsibilities as COO,” said Hirschhorn. “I look forward to working closely with our talented and streamlined leadership team to sharpen our operational focus on key priorities, drive greater efficiencies, optimize cash flow and deliver profitable growth while pursuing our mission to redefine healthcare delivery through technology-driven solutions.”
Departing Executives
As part of this restructuring, Chief Commercial and Growth Officer Kathy Weiler and Chief Operating Officer Kurt Knight will be leaving Amwell at the end of the year. Both executives have made significant contributions to the company’s growth and development. Weiler played a key role in implementing cost-saving initiatives and transforming Amwell’s growth organization during her tenure.
Knight has been with Amwell for 14 years, contributing to various strategic initiatives, including M&A, the company’s IPO, and the rapid scaling of operations during the COVID-19 pandemic. He also played a crucial role in building and managing Amwell Medical Group, the company’s affiliated network of providers.
